Avelumab with axitinib for untreated advanced renal cell carcinoma

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee C.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chairs

Stephen O'Brien and Richard Nicholas
Chairs, technology appraisal committee C

NICE project team

Each evaluation is assigned to a team consisting of 1 health technology analyst (who act as a technical lead for the evaluation), a technical adviser, a project manager and an associate director.

Anuja Chatterjee
Technical lead

Rachel Williams
Technical adviser

Louise Jafferally and Leena Issa
Project managers

Ross Dent
Associate director

ISBN: 978-1-4731-7652-2